bioRxivBiochemistryPreprint
Modulation of human kinase activity through direct interaction with SARS-CoV-2 proteins
B. Halwachs, C. S. Moesslacher, J. M. Kohlmayr, S. Fasching, S. Masser, S. A. Choteau, A. Zanzoni, N. Kunowska, U. Stelzl
Abstract
The dysregulation of cellular signaling upon SARS-CoV-2 infection is mediated via direct protein interactions, with the human protein kinases constituting the major impact nodes in the signaling networks. Here, we employed a targeted yeast two-hybrid matrix approach to identify direct SARS-CoV-2 protein interactions with an extensive set of human kinases. We discovered 51 interactions involving 14 SARS-CoV-2 proteins and 29 human kinases, including many of the CAMK and CMGC kinase family members, as well as non-receptor tyrosine kinases. By integrating the interactions identified in our screen with transcriptomics and phospho-proteomics data, we revealed connections between SARS-CoV-2 protein interactions, kinase activity changes, and the cellular phospho-response to infection and identified altered activity patterns in infected cells for AURKB, CDK2, CDK4, CDK7, ABL2, PIM2, PLK1, NEK2, TRIB3, RIPK2, MAPK13, and MAPK14. Finally, we demonstrated direct inhibition of the FER human tyrosine kinase by the SARS-CoV-2 auxiliary protein ORF6, hinting at pressures underlying ORF6 changes observed in recent SARS-CoV-2 strains. Our study expands the SARS-CoV-2 - host interaction knowledge, illuminating the critical role of dysregulated kinase signaling during SARS-CoV-2 infection.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A map of binary SARS-CoV-2 protein interactions implicates host immune regulation and ubiquitination
Dae‐Kyum Kim, Benjamin Weller, … Pascal Falter‐Braun·Nature BiotechnologyPeer-reviewed·Oct 10, 2022
- The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
T. M. Yaron, B. E. Heaton, … M Kavanagh-Williamson·bioRxiv·Aug 14, 2020
- Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for therapy
- Antiviral Drug Screen of Kinase inhibitors Identifies Cellular Signaling Pathways Critical for SARS-CoV-2 Replication
G. Garcia, A. Sharma, … V. Arumugaswami·Cell ReportsPeer-reviewed·Apr 1, 2021
- Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses
Dennis Salomon Lopez Molina, Nazim Ahnou, … Abdelhakim Ahmed‐Belkacem·bioRxiv·Oct 5, 2026
- SARS-CoV-2 hijacks p38β/MAPK11 to promote viral protein translation
C. A. Higgins, B. E. Nilsson-Payant, … J. R. Johnson·bioRxiv·Aug 20, 2021